Dataset Information


Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.

ABSTRACT: DNA methylation is an essential epigenetic marker associated with the silencing of gene expression. Although various genome-wide studies revealed aberrantly methylated gene targets as molecular biomarkers for early detection, the survival rate of lung cancer patients is still poor. In order to identify methylation-driven biomarkers, genome-wide changes in DNA methylation and differential expression in 32 pairs of lung adenocarcinoma and adjacent normal lung tissue in non-smoking women were examined. This concurrent analysis identified 21 negatively correlated probes (r???-0.5), corresponding to 17 genes. Examining the endogenous expression in lung cancer cell lines, five of the genes were found to be significantly down-regulated. Furthermore, in tumor cells alone, 5-aza-2'-deoxycytidine treatment increased the expression levels of STXBP6 in a dose dependent manner and pyrosequencing showed higher percentage of methylation in STXBP6 promoter. Functional analysis revealed that overexpressed STXBP6 in A549 and H1299 cells significantly decreased cell proliferation, colony formation, and migration, and increased apoptosis. Finally, significantly lower survival rates (P?


PROVIDER: S-EPMC5309775 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7606008 | BioStudies
2020-01-01 | S-EPMC7606000 | BioStudies
1000-01-01 | S-EPMC5774002 | BioStudies
2017-01-01 | S-EPMC5345611 | BioStudies
2020-01-01 | S-EPMC7418817 | BioStudies
2020-01-01 | S-EPMC7056714 | BioStudies
2018-01-01 | S-EPMC6171826 | BioStudies
2020-01-01 | S-EPMC6910195 | BioStudies
2018-01-01 | S-EPMC6443096 | BioStudies
2020-01-01 | S-EPMC7590431 | BioStudies